跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MAR-OSELTAMIVIR - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
MAR-OSELTAMIVIR
Authorized
STANDARD
MAR-OSELTAMIVIR
marcan pharmaceuticals inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
145338f72e16c8b9
Company
marcan pharmaceuticals inc
Type
Standard
Approval Details
Approval Id
145338f72e16c8b9
Drug Approval Canada Name
MAR-OSELTAMIVIR
Product Name
MAR-OSELTAMIVIR
Status
Cancelled Post Market
Status Date
2024-05-13
Original Market Date
2020-09-17
Din
02497360
Drug Class
Human
Dosage Form
Capsule
Route Of Administration
Oral
Schedule
Prescription
Ahfs
08:18.28
Atc Original
J05AH02 OSELTAMIVIR
Atc Name
j 05 ah 02
Aig Number
0139501004
Company Name
marcan pharmaceuticals inc
Company Address
2 Gurdwara Rd., Suite 112, Ottawa, Ontario, Canada, K2E 1A2
Active Ingredients
OSELTAMIVIR (OSELTAMIVIR PHOSPHATE)
45 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
145338f72e16c8b9
Type
Standard
Back to Health Canada Approvals